Last reviewed · How we verify
NCT04032808
Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD)
trial in Age-related Macular Degeneration in 70 participants. Status unknown.
10 July 2021
Quick facts
| Lead sponsor | Clinique Beau Soleil |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 10 July 2019 |
| Primary completion | 10 July 2021 |
| Estimated completion | 10 July 2021 |
| Sites | 1 location across France |
Conditions studied
- Age-related Macular Degeneration — all drugs for Age-related Macular Degeneration →
Sponsor
Clinique Beau Soleil
Who can join
50 and older, any sex, with Age-related Macular Degeneration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monocentric and prospective study, evaluating the benefit of self-monitoring optimized by therapeutic education either by the environmental Amsler or the Amsler grid according to the patient's choice and to determine the patient's ability to determine the reality itself recidivism and therefore the need for treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04032808
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Age-related Macular Degeneration
Currently open trials in the same condition.
- NCT06961370 — A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO76693 · Phase 1 · recruiting
- NCT06458595 — Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) · Phase 1, PHASE2 · recruiting
- NCT03848663 — Visual Remapping to Aid Reading With Field Loss · NA · recruiting
- NCT04735263 — Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD · Phase 2 · recruiting
- NCT03752840 — Village-Integrated Eye Worker Trial II · NA · recruiting
Other Clinique Beau Soleil trials
Trials by the same sponsor.
- NCT07473011 — Study of the Effect of Spa Therapy on Insomnia · not yet recruiting
- NCT07398833 — Modulation of Working Memory by an Alternating Magnetic Field in Humans · NA · not yet recruiting
- NCT06486961 — Effect of Walking With Music in Obese People (BeatMove) · NA · recruiting
- NCT04647981 — Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. · completed
- NCT04028934 — Study of the Quality of Life of Patients Treated by Heavy Surgery as Part of an Enhanced Recovery at Beau Soleil Clinic- · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04032808 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinique Beau Soleil
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04032808.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing